IN THE NEWS: Dr. Yang Highlights Positive COMMANDS Trial Data for Luspatercept in MDS

 

Targeted Oncology

During a case study discussion, Jay Yang, M.D., hematologist, medical oncologist, and leader of the Hematology Oncology Multidisciplinary Team at Karmanos, discussed the results from a clinical trial that compared luspatercept to erythropoietin-stimulating agent (ESA) when treating myelodysplastic syndrome.

Read the article here.

Jay Yang, M.D.